Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-022538

EVP, Head of North America sold 1,638 shares at an average $50.80 ($83,207)

  • EVP, Head of North America acquired 5,469 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lee Jennifer Kayden · EVP, Head of North America

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-09 Exercise or conversion : show line 1 in the form +3,438 6,459 D
2024-02-11 Exercise or conversion : show line 2 in the form +2,031 8,490 D
2024-02-12 Sale : show line 3 in the form −1,023 $51.38 $52,562 7,467 D
2024-02-13 Sale : show line 4 in the form −615 $49.83 $30,645 6,852 D
Open-market sales · 1,638 sh · avg $50.80 · $83,207

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-09 Exercise or conversion : show line 5 in the form Restricted Stock Units −3,438 6,874 D
2024-02-11 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,031 2,031 D
Loading xslF345X05/tm246165-3_4seq1.xml…